Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole
Sofía Siscar-Lewin,Toni Gabaldón,Alexander M. Aldejohann,Oliver Kurzai,Bernhard Hube,Sascha Brunke,Sascha BrunkeaDepartment of Microbial Pathogenicity Mechanisms,Hans Knoell Institute,Jena,GermanybBarcelona Supercomputing Centre (BSC-CNS),Barcelona,SpaincInstitute for Research in Biomedicine (IRB Barcelona),The Barcelona Institute of Science and Technology,Barcelona,SpaindCatalan Institution for Research and Advanced Studies (ICREA),Barcelona,SpaineInstitute for Hygiene and Microbiology,Julius-Maximilians-University,Würzburg,GermanyfInstitute of Microbiology,Friedrich Schiller University,Jena,Germany,Deborah A. Hogan
DOI: https://doi.org/10.1128/mBio.01128-21
IF: 6.4
2021-06-03
mBio
Abstract:Loss or inactivation of antivirulence genes is an adaptive strategy in pathogen evolution. Candida glabrata is an important opportunistic pathogen related to baker's yeast, with the ability to both quickly increase its intrinsic high level of azole resistance and persist within phagocytes. During C. glabrata 's evolution as a pathogen, the mitochondrial DNA polymerase CgMip1 has been under positive selection. We show that CgMIP1 deletion not only triggers loss of mitochondrial function and a petite phenotype, but increases C. glabrata 's azole and endoplasmic reticulum (ER) stress resistance and, importantly, its survival in phagocytes. The same phenotype is induced by fluconazole and by exposure to macrophages, conferring a cross-resistance between antifungals and immune cells, and can be found in clinical isolates despite a slow growth of petite strains. This suggests that petite constitutes a bet-hedging strategy of C. glabrata and, potentially, a relevant cause of azole resistance. Mitochondrial function may therefore be considered a potential antivirulence factor. IMPORTANCE Candida glabrata is an opportunistic pathogen whose incidence has been increasing in the last 40 years. It has risen to become the most prominent non- Candida albicans Candida (NCAC) species to cause candidemia, constituting about one-third of isolates in the United States, and steadily increasing in European countries and in Australia. Despite its clinical importance, C. glabrata 's pathogenicity strategies remain poorly understood. Our research shows that loss of mitochondrial function and the resulting petite phenotype is advantageous for C. glabrata to cope with infection-related stressors, such as antifungals and host immune defenses. The (cross-)resistance against both these factors may have major implications in the clinical outcome of infections with this major fungal pathogen.
microbiology